Up-regulation of 42 kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3331-3336

  Kuramitsu, Yasuhiro ^a   Takashima, Motonari ^a   Yokoyama, Yuichiro ^a   Iizuka, Norio ^a   Tamesa, Takao ^a   Akada, Junko K ^a   Wang, Yufeng ^a   Toda, Toshifusa ^b   Sakaida, Isao ^a   Okita, Kiwamu ^a   Oka, Masaaki ^a   Nakamura, Kazuyuki ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

2 DE; HCV HCC; MS; Proteomics; Tubulin alpha 6 chain

Indexed keywords

ALPHA TUBULIN; BIOLOGICAL MARKER; GLUTAMATE AMMONIA LIGASE;

ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; GEL ELECTROPHORESIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CELL CARCINOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR DIFFERENTIATION;

AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOBLOTTING; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; TUBULIN; UP-REGULATION;

EID: 80054724190     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. El-Serag HB and Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Eng J Med 340: 745-750, 1999. (Pubitemid 29114292)
2. Tanaka E and Kiyosawa K: Natural history of acute hepatitis C. Gastroenterol Hepatol 15: E97-E104, 2000. (Pubitemid 30435744)
3. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hürter D, Nawrocki M, Kruska L, Hensel F, Petry W and Häussinger D: Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 28: 1687-1695, 2003.
4. Okuda K: Hepatocellular carcinoma. J Hepatol 32: 225-237, 2000.
5. Kuramitsu Y and Nakamura K: Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma. Expert Rev Proteomics 2: 589-601, 2005. (Pubitemid 41139841)
6. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Toda T, Saiakida I, Okita K, Oka M and Nakamura K: Proteomic profiling of heat-shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 3: 2487-2493, 2003. (Pubitemid 38010125)
7. Yokoyama Y, Kuramitsu Y, Takashima M, Iizuka N, Toda T, Terai S, Sakaida I, Oka M, Nakamura K and Okita K: Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 4: 2111-2116, 2004. (Pubitemid 38880376)
8. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Sakaida I, Okita K, Oka M and Nakamura K: Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 6: 3894-3900, 2006. (Pubitemid 44065166)
9. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Nishisaka T, Sakaida I, Okita K, Oka M and Nakamura K: Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5: 1686-1692, 2005. (Pubitemid 40593274)
10. Kuramitsu Y, Harada T, Takashima M, Yokoyama Y, Hidaka I, Iizuka N, Toda T, Fujimoto M, Zhang X, Sakaida I, Okita K, Oka M and Nakamura K: Increased expression, and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues of patients infected with hepatitis C virus. Electrophoresis 27: 1651-1658, 2006.
11. Tanaka T, Kuramitsu Y, Fujimoto M, Naito S, Oka M and Nakamura K: Down-regulation of two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) correlates with high metastatic potentials of human SN12C renal cell carcinoma cell clones. Electrophoresis 29: 2651-2659, 2008. (Pubitemid 351911893)
12. Wade RH: On and around microtubules: an overview. Mol Biotechnol 43: 177-191, 2009.
13. Yue QX, Liu X and Guo DA: Microtubule-binding natural products for cancer therapy. Planta Med 76: 1037-1043, 2010.
14. Perez EA: Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther 8: 2086-2095, 2009.
15. Matos JM, Witzmann FA, Cummings OW and Schmidt CM: A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States. J Surg Res 155: 237-243, 2008.
16. He ZY, Wen H, Shi CB and Wang J: Up-regulation of hnRNP A1, ezrin, tubulin β-2C and annexin A1 in sentinel lymph nodes of colorectal cancer. World J Gastroenterol 16: 4670-4676, 2010.
17. Cho SJ, Jin LJ, Kim BY, Cho SI, Jung WY, Han JH, Ha SY, Kim HK and Kim A: Increased expression of matrix metalloproteinase 9 and tubulin-alpha in pulmonary sclerosing hemangioma. Oncol Rep 18: 1139-1144, 2007.
18. Jeong HC, Kim GI, Cho SH, Lee KH, Ko JJ, Yang JH and Chung KH: Proteomic analysis of human small cell lung cancer tissues: up-regulation of coactosin-like protein-1. J Proteome Res 10: 269-276, 2011.
19. Seliger B, Dressler SP, Wang E, Kellner R, Recktenwald CV, Lottspeich F, Marincola FM, Baumgärtner M, Atkins D and Lichtenfels R: Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma. Proteomics 9: 1567-1581, 2009.
20. Qi Y, Chiu JF, Wang L, Kwong DL and He QY: Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 5: 2960-2971, 2005. (Pubitemid 41059772)
21. Wu C, Luo Z, Chen X, Wu C, Yao D, Zhao P, Liu L, Shi B and Zhu L: Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Oncol Rep 21: 1429-1437, 2009.
22. Lim R, Lappas M, Ahmed N, Permezel M, Quinn MA and Rice GE: 2D-PAGE of ovarian cancer: analysis of soluble and insoluble fractions using medium-range immobilized pH gradients. Biochem Biophys Res Commun 406: 408-413, 2011.